Inventor · disambiguated record
Maninder Hora
Also filed as: HORA MANINDER · HORA MANINDER S · HORA MANINDER SINGH
27 granted patents·8 pending applications·767 citations·filing 1989–2019
97Inventor score
Top patents by PatentIndex Score
35 records- 0198US6525102B1Stabilized liquid polypeptide-containing pharmaceutical compositionsCHIRON CORP·Filed 2000·Granted Feb 25, 2003·148 cites·58 claims
- 0295US7371373B2HSA-free formulations of interferon-βNOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted May 13, 2008·50 cites·25 claims
- 0394US7807142B2Stabilized liquid polypeptide-containing pharmaceutical compositionsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Oct 5, 2010·24 cites·21 claims
- 0493US5730969AMethod and compositions for solubilization and stabilization of polypeptides, especially proteinsCHIRON CORP·Filed 1995·Granted Mar 24, 1998·133 cites·79 claims
- 0590US9545440B2Methods for preparing squaleneNOVARTIS AG·Filed 2015·Granted Jan 17, 2017·6 cites·47 claims
- 0689US6887462B2HSA-free formulations of interferon-betaCHIRON CORP·Filed 2001·Granted May 3, 2005·30 cites·113 claims
- 0786US5997856AMethod and compositions for solubilization and stabilization of polypeptides, especially proteinsCHIRON CORP·Filed 1989·Granted Dec 7, 1999·71 cites·24 claims
- 0885US9867877B2Methods for preparing squaleneNOVARTIS AG·Filed 2016·Granted Jan 16, 2018·3 cites·33 claims
- 0985US7662369B2Stabilized interferon compositionsNOVARTIS AG·Filed 2005·Granted Feb 16, 2010·3 cites·47 claims
- 1084US6753015B2Microparticle compositions and methods for the manufacture thereofCHIRON CORP·Filed 2001·Granted Jun 22, 2004·30 cites·51 claims
- 1184US6306432B1High and low load formulations of IGF-I in multivesicular liposomesCHIRON CORP·Filed 1997·Granted Oct 23, 2001·74 cites·42 claims
- 1284US5078997APharmaceutical composition for interleukin-2 containing physiologically compatible stabilizersCETUS CORP·Filed 1989·Granted Jan 7, 1992·76 cites·14 claims
- 1383US7399463B2HSA-free formulations of interferon-betaNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Jul 15, 2008·13 cites·26 claims
- 1483US7030086B2Stabilized liquid polypeptide-containing pharmaceutical compositionsCHIRON CORP·Filed 2002·Granted Apr 18, 2006·13 cites·46 claims
- 1582US9199897B2Methods for preparing squaleneHORA MANINDER·Filed 2011·Granted Dec 1, 2015·6 cites·13 claims
- 1681US7335639B2IGF-1 composition and its useNOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Feb 26, 2008·1 cites·6 claims
- 1779US11077186B2Methods for preparing squaleneNOVARTIS AG·Filed 2019·Granted Aug 3, 2021·0 cites·18 claims
- 1879US10517947B2Methods for preparing squaleneNOVARTIS AG·Filed 2017·Granted Dec 31, 2019·1 cites·16 claims
- 1978US7892531B2HSA-free formulations of interferon-βNOVARTIS VACCINES & DIAGNOSTIC·Filed 2008·Granted Feb 22, 2011·2 cites·7 claims
- 2078US6994847B2Stabilized interferon compositionsCHIRON CORP·Filed 2001·Granted Feb 7, 2006·7 cites·77 claims
- 2177US5888968ATFPI formulationCHIRON CORP·Filed 1996·Granted Mar 30, 1999·31 cites·14 claims
- 2275US7226757B2Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitorNOVARTIS VACCINES & DIAGNOSTIC·Filed 2006·Granted Jun 5, 2007·1 cites·31 claims
- 2373US7846479B2Microparticle compositions and methods for the manufacture thereofNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Dec 7, 2010·6 cites·23 claims
- 2470US2008171071A1Novel IGF-1 composition and its useCHIRON CORP·Filed 2007·Application pending·0 cites
- 2565US6319896B1Method of solubilizing, purifying, and refolding proteinCHIRON CORP·Filed 1999·Granted Nov 20, 2001·15 cites·24 claims
- 2662US6573238B2Method for producing sustained-release formulationsCHIRON CORP·Filed 1998·Granted Jun 3, 2003·23 cites·39 claims
- 2762US2006159679A1Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variantsCHIRON CORP·Filed 2006·Application pending·0 cites
- 2860US2004180827A1Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variantsCHIRON CORP·Filed 2004·Application pending·0 cites
- 2959US2008281084A1Formulation, Solubilization, Purification, and Refolding of Tissue Factor Pathway InhibitorNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Application pending·0 cites
- 3058US2003198602A1Methods for pulmonary delivery of interleukin-2CHIRON CORP·Filed 2003·Application pending·0 cites
- 3158US2007249522A1Injectable formulations containing succinateNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Application pending·0 cites
- 3255US2008003294A1Methods for pulmonary delivery of interleukin-2NOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Application pending·0 cites
- 3350US8333958B2HSA-free formulations of interferon-BetaSHIRLEY BRET A·Filed 2011·Granted Dec 18, 2012·0 cites·43 claims
- 3440US2003124139A1Compositions and methods for stabilizing biological molecules upon lyophilizationFiled 2000·Application pending·0 cites
- 3531US7067485B2IGF-I composition and its useCHIRON CORP·Filed 1998·Granted Jun 27, 2006·0 cites·32 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →